INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 99 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $30,000 | -46.4% | 26,504 | +5.9% | 0.00% | – |
| Q4 2021 | $56,000 | -54.1% | 25,017 | -29.9% | 0.00% | – |
| Q3 2021 | $122,000 | +19.6% | 35,706 | +4.8% | 0.00% | – |
| Q2 2021 | $102,000 | -30.6% | 34,064 | +153.0% | 0.00% | – |
| Q2 2015 | $147,000 | -27.2% | 13,465 | -15.1% | 0.00% | – |
| Q2 2014 | $202,000 | -12.9% | 15,861 | +19.2% | 0.00% | – |
| Q3 2013 | $232,000 | -10.1% | 13,305 | -16.3% | 0.00% | -100.0% |
| Q2 2013 | $258,000 | – | 15,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $819,180 | 0.18% |
| BVF INC/IL | 6,353,645 | $3,526,273 | 0.15% |
| Gratus Capital, LLC | 1,323,598 | $734,600 | 0.06% |
| Bleichroeder LP | 250,000 | $138,750 | 0.03% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $302,757 | 0.01% |
| Callan Capital, LLC | 158,500 | $87,968 | 0.01% |
| Polar Capital Holdings Plc | 2,071,242 | $1,149,539 | 0.01% |
| Virtu Financial LLC | 66,537 | $37 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $138,195 | 0.00% |
| Pacific Sage Partners, LLC | 17,500 | $9,713 | 0.00% |